Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Oncolytic adenovirus therapy using a prostate-specific conditionally replication-competent adenovirus as an adjuvant treatment for localised prostate cancer

Proposed period of release:
01/11/2012 to 01/11/2022

Name of the Institute(s) or Company(ies)

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
Genus Mastadenovirus, species human Adenovirus subgenus C, serotype 5.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
Human adenovirus type 5Mastadenovirushuman adenovirussubgenus Chuman serotype 5-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known